DEADLINE(S)SPONSOROPPORTUNITY TITLE/LINKADDITIONAL INFORMATION

Applications accepted on rolling basis; scientific review occurs in June and December

23andMeResearch Innovation Collaborations ProgramAs related to COVID-19, 23andMe will consider studies of outcomes, co-morbidities, health disparities and impacts of policies implemented to address the pandemic. Academic researchers are paired with 23andMe scientists and gain access to de-identified data from the 23andMe Research Cohort.
Required Letters of Intent due February 18, 2021; invited full applications are then due April 30, 2021American Lung Association (ALA)COVID-19 and Emerging Respiratory Viruses Research AwardsALA will support clinical, basic, translational and population health research projects related to: 1) A new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention; 2) Understanding host factors that alter response to these infections; 3) Understanding individual, regional or social factors increasing or decreasing community spread of COVID-19 and other respiratory viruses; and 4) Case tracking and epidemiological approaches to understanding COVID-19 and other respiratory viruses.
Continuous submissionArgonne National Laboratory (US Department of Energy)Expedited, Rapid Access Call for COVID-19 Research SupportThe Advanced Photon Source at Argonne is offering remote access to beamlines for macromolecular crystallography and BioSAXS for research efforts related to SARS-CoV-2 or COVID-19.
No deadline indicatedArmy Applications Laboratory (AAL)COVID-19 InnovationsAAL is seeking information on innovative medical equipment, therapeutics, diagnostics and vaccines relative to COVID-19. The first step is to schedule a telephone call with the agency to discuss your innovative idea(s).
January 31, 2021Asian Development Bank (ADB)COVID-19 Vaccine Safety and Immunization MonitoringThis opportunity is open to investigators world-wide, and is focused on finding digital solutions to help ADB's developing member countries address challenges as vaccines become available specific to safety/immunization and tracking of administered vaccines.

March 17, 2021

Basic Behavioral and Social Science Opportunity Network (NIH OPPNET)Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Well-Being, Illness and Recovery (R01)This Notice adds a deadline date and interests specific to COVID-19.
No deadline specifiedBoehringer IngelheimInvestigator-Initiated Studies (IIS): Established ProductsThe sponsor's purpose is to evaluate potential clinical and non-clinical investigations involving COVID-19 related matters including safety, clinical outcomes, antiviral effects or antithrombotic benefits.
Continuous submissionBrookhaven National Laboratory (US Department of Energy)COVID-19 Research SupportThe Center for Biomolecular Structure is supporting remote macromolecular crystallography experiments at the AMX and FMX beamlines and solution scattering experiments at the LiX beamline for COVID-19 research.

Letters of intent are due January 18, 2021; full applications are then due February 18, 2021

Note this funding opportunity limits the University to one application.

Centers for Disease Control and Prevention (CDC)Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality” (RFA-GH-21-004) Note this is a limited opportunity; our internal selection process runs through the Office of the Vice Chancellor for Research. The purpose of this RFA is to understand the needs of emergency-affected and displaced populations and estimate morbidity and mortality in the context of the COVID-19 pandemic. In order to achieve these overarching goals, the following objectives are proposed among displaced populations affected by humanitarian emergencies: 1) To develop more accurate and refined systems based on evidence-based implementation generated by comparing various mortality surveillance, mortality surveys and cause of death methods specific for humanitarian settings; 2) To compare surveillance and mitigation strategies to better understand disease transmission among emergency-affected populations and develop evidence-based guidelines for the effectiveness and impact of various interventions in humanitarian settings; 3) To leverage a prospective research design to further our understanding of disease transmission, trajectory, secondary and longer-term outcomes of the COVID-19 pandemic among displaced persons; 4) To study hand hygiene activities and evaluate how types of hardware (handwashing stations, soaps, hand gels) and behavior change interventions effect COVID-19  transmission and document the health impact of handwashing interventions on COVID19, and enteric or respiratory diseases; 5) To conduct innovative research including randomized controlled trials on the effectiveness and impact of various mental health interventions, programs and services, and develop evidence-based guidelines in humanitarian settings.

Optional letters of intent are due January 20, 2021

Full applications are due February 22, 2021

Note the University is limited to one application

Centers for Disease Control and Prevention Center for Global HealthStrengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally (RFA-GH-21-006)

The initial focus for grantees of this program will be on conducting sero-epidemiologic activities that focus on collection of important information about the extent, duration of and risk factors for infection with SARS-CoV-2 in general or priority populations, and/or approaches to conducting sero-surveillance work. Projects are to be focused on one to four prioritized countries within the following regions as specified in the RFA: Africa, Southeast Asia, Middle East and North Africa and Eastern Europe and Central Asia.

NOTE THIS IS A LIMITED OPPORTUNITY; OUR INTERNAL SELECTION PROCESS RUNS THROUGH THE OFFICE OF THE VICE CHANCELLOR FOR RESEARCH.

Optional letters of intent are due January 7, 2021

Full applications are due February 8, 2021

Note the University is limited to one application

Centers for Disease Control and Prevention National Center for Immunization and Respiratory DiseasesUS Enhanced Surveillance Network to Assess Burden, Natural History and Effectiveness of Vaccines to Prevent Enteric and Respiratory Diseases in Children (RFA-IP-21-002)

The goal of this funding opportunity is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for 1) acute gastroenteritis; 2) acute respiratory illnesses due to respiratory viruses (to include SARS-CoV-2); and 3) acute flaccid myelitis syndrome and multisystem inflammatory syndrome in children.

NOTE THIS IS A LIMITED OPPORTUNITY; OUR INTERNAL SELECTION PROCESS RUNS THROUGH THE OFFICE OF THE VICE CHANCELLOR FOR RESEARCH.

Proposals may be submitted any time; note that interested researchers should respond quickly as Cisco withdraws RFPs when they determine they have met the program goal.Cisco Systems, Inc.

Future of Work (RFP-21-02)

(Scroll down to see open Requests for Proposals)

In light of COVID-19 and the new reality of working from home indefinitely that the pandemic has brought us, Cisco Research Center has released this RFP to encourage research aimed at making the remote work environment more ideal.
Continuous submission until closed by sponsorCisco Systems, Inc.

Tech for Health (RFP-21-04)

(Scroll down to see open Requests for Proposals)

 
Cisco is interested in funding research related to applications of technology for health care purposes. Pandemic related sponsor interests include sensor technologies, scalable monitoring of public health protocols such as mask wearing, systems for scalable contact tracing and many others.
Applications accepted anytime until funds are depleted for the yearComcastInnovation Fund: Research GrantsComcast is interested in receiving proposals related to COVID-19 effects on the Internet among other topics.
Applications accepted on rolling basisCOVID-19 Early Treatment Fund (CETF)Grants ProgramAdvocating early, effective treatment for COVID-19 patients designed to prevent hospitalization, CETF is supporting outpatient clinical trials of re-purposed antiviral drugs. 
Continuous submissionDepartment of Energy
(US DOE)
Dear Colleague Letter - Corona Virus Disease 2019 (COVID-19)DOE is encouraging submission of scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.
Continuous submissionDepartment of Energy (DOE)Rapid Access for COVID-19 ResearchDOE is offering remote access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapeutics.
October 31, 2021 
(this is final white paper submission deadline; full proposals will be invited by the sponsor)
Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)Broad Agency Announcement (BAA)BARDA has updated this BAA to reflect its current Areas of Interest (AOI), all related to COVID-19: 
AOI 7.7.1 Diagnostic assay for human coronavirus using existing FDA-cleared platforms; 

AOI 7.7.2 Point-of-care diagnostic assay for  detection of SARS-CoV-2 virus; 
AOI 7.7.3 Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection), Including Serology Tests
AOI 7.7.4 Diagnostic Assay for SARS-CoV-2 as part of FDA-cleared panel for influenza and other respiratory viruses using FDA-cleared platforms
AOI 9.2 COVID-19 Therapeutics
AOI 17 Advanced Manufacturing Technologies

 

February 3, 2023 or until rescinded for AOI #1, AOI #2 and AOI #6) 

Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)

Division of Research Innovations and Ventures Easy Broad Agency Announcement (DRIVe)

See DRIVe EZ BAA Special Instructions 012 for details on AOI #1, AOI #2 and AOI #6

An update from 10/22/20 indicates the sponsor has added AOIs to the Broad Agency Announcement that can relate to, but are not specific to, COVID-19: AOI #1 - Early Notification to Act, Control and Treat (ENACT); AOI #2 - Infection Severity and Solving Sepsis; and AOI #6 - Beyond the Needle.

Continuous SubmissionDiamond Light SourceRapid Access Call for Proposals: SARS-CoV-2Diamond, the UK's national synchotron, is offering its facilities and fragment screening expertise to researchers world-wide who are working on COVID-19 related projects.
Applications accepted on rolling basisEmergent VenturesFast Grants for COVID-19The sponsor provides funding for researchers at academic institutions who are currently working on scientific or biomedical COVID-19 projects that could help with the pandemic within the next 6 months. Funding decisions are promised within 14 days for this second round of funding. This grant program is administered by the Mercatus Center at George Mason University.
Applications accepted on a rolling basisEuro Bio-ImagingFast Track Access to Biological and Biomedical Imaging Technologies for COVID-19 Research ProjectsScientists worldwide with ongoing COVID-19 research projects in need of imaging resources will want to consider this opportunity. The sponsor is offering to facilitate access to over 40 biological and biomedical imaging technologies, supporting basic research efforts as well as medical applications and diagnostics.
Continuous submissionExtreme Science and Engineering Discovery Environment (XSEDE)
(funded by the National Science Foundation)
COVID-19 HPC Consortium

This Consortium houses some of the most powerful and advanced computers in the world which will be made available to researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections.

No deadlineFacebookCrowdTangle Public Application for AcademicsUsing Facebook's CrowdTangle, designed to enhance abilities to follow, analyze and report on what's happening across social media, this opportunity will allow researchers to gain access to CrowdTangle tools/technical support. Projects should be focused on misinformation, elections, COVID-19, racial justice and/or well-being. Applications are for access to CrowdSource; no funding is associated with this opportunity.
No deadlinesFacebookNew Preventive Health Survey Data Available for ResearchFacebook has partnered with the Massachusetts Institute for Technology (MIT) Initiative on the Digital Economy and Johns Hopkins University Center for Communication Programs to launch a Preventive Health Survey, designed to assess the public's knowledge, attitude and practices about COVID-19 prevention. Researchers are invited to request aggregated, de-identified survey data; access to  microdata may also be requested but requires a signed data use agreement.
None indicatedFacebookSymptom SurveysFacebook is offering access to survey data collected on a national and global level concerning Facebook users and COVID-19 symptoms. The Symptom Survey datasets are managed by Carnegie Mellon University and the University of Maryland. Academic and non-profit researchers may request access to the aggregated survey data. See the website for more details on survey methodology and the process for requesting data access.
Continuous submission until program funds are expended or the COVID-19 pandemic has endedFederal Communications Commission (FCC)COVID-19 Telehealth ProgramAvailable funding of $200 million for this program comes from the recently enacted CARES Act. It's designed to pay eligible health care providers (to include postsecondary educational institutions offering health care instruction, teaching hospitals and medical schools) to provide connected care services for patients by funding telecommunications services, information services and necessary devices. This is not a grant program; instead, after initial approval, provider expenses related to COVID-19 telehealth services for patients will be reimbursed (starting with expenses incurred after March 13, 2020).
Submissions will be uploaded on the FIND website on a rolling basisFoundation for Innovative New Diagnostics (FIND)Open Call for Data - COVID-19

This Switzerland-based non-profit is asking laboratories around the world with any performance data on commercially available in vitro diagnostic tests that detect nucleic acid, viral antigen or antibodies to contribute to a centralized collection of data as a global public good. The data compilation will be made available on the FIND website to enable fast data sharing throughout the diagnostic community. 

Applications accepted on a continuous basisFoundation for Opioid Response Efforts (FORE)Strengthening Access to Care for Opioid Use Disorder Patients During the COVID-19 National Public Health Emergency: Recovery Support ServicesFORE will fund projects designed to provide evidence-based opioid use disorder recovery support services in the context of social distancing and infection control including promotion of remote, digital and virtual forms of recovery support to reach vulnerable and high-risk populations. Populations of interest include rural communities, urban and minority communities, children and adolescents, pregnant and parenting women, veterans, justice-involved individuals, homeless individuals, the LGBT community, and Native Americans and tribal communities.
No deadline indicatedGinkgo BioworksAccess to Platform for Partner COVID-19 ProjectsThe sponsor is offering access to its platform for company and academic labs engaged in developing a diagnostic, drug or vaccine to stop COVID-19.
Applications accepted on a rolling basisGoogle, Inc.COVID-19 Research Credits ProgramGoogle is offering support in the form of Google Cloud research credits to be used for computing services (e.g., storage, computation, data analysis) on Google Cloud Platform for COVID-19 research projects. Note the research credits are meant to fully fund the described project, and credit awards last 90 days.
Ongoing review

William T. Grant Foundation

Spencer Foundation

Rapid Response Research GrantsThe Grant Foundation will use the Rapid Response Research Grants mechanism to fund projects designed to combat youth inequality in the US, a main priority of the Foundation, made worse by the COVID-19 Pandemic. They are joined by the Spencer Foundation in this endeavor. These grants will fund collaborations between researchers and policymakers. Researchers on the team synthesize relevant literature within 6-8 weeks from the start of the grant award, and work with their policy partners to ensure the research results in actions benefiting youth.
Proposals accepted on a rolling basisInnovations for Poverty Action (IPA)Competitive Fund for Peace and Recovery: COVID-19 ResponseIPA is accepting off-cycle proposals for time-sensitive additions to ongoing research projects that study or support the COVID-19 response such as 1) adding a module to a current survey to track COVID-19 exposure/response; 2) adding a treatment arm to support communities' resiliency in response to COVID-19; 3) Preparing already collected data for sharing quickly.
Phase 1 Brief Proposals may be submitted anytime; full proposals will be invited by the sponsorRobert Wood Johnson Foundation (RWJF)Pioneering Ideas: Exploring the Future to Build a Culture of HealthRWJF is looking for future-focused projects in four focus areas to benefit their overall Foundation theme - Building a Culture of Health: 1) Future of Evidence, 2) Future of Social Interaction, 3) Future of Food and 4) Future of Work. Emphasis is on health equity. The sponsor notes that while this opportunity is focused on broader trends evolving prior to COVID-19, they are open to projects addressing the pandemic, either directly or indirectly.
This program is currently on pause; if they find a sponsor, they plan to re-open.Mercatus Center (at George Mason University)COVID-19 Response: A Call for IdeasThe sponsor is seeking proposals for policy briefs, working papers and articles addressing the next COVID-19 challenges facing the US and other countries: Reopening and restarting; institutional challenges, health and science policy; economic and regulatory policy; and monetary policy.
Applications accepted on rolling basisMozilla Open Source Support Program (MOSS)COVID-19 Solutions FundMOSS will fund open source technology projects related to COVID-19. Projects should be relatively well along as awardees are expected to use funds within 3 months of receipt.
Applications accepted through March 29, 2021National Aeronautics and Space Administration (NASA)Rapid Response and Novel Research in Earth Science ProposalNASA will provide new or additional support for studies using NASA satellite data to address regional-to-global environmental, economic and/or societal impacts of the COVID-19 pandemic. NASA is encouraging use of artificial intelligence/machine learning techniques.
Continuous submission (contact program officer first)National Cancer Institute (NCI)Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-Supported Projects to be Redirected to COVID-1-Related Research during the CrisisNCI-funded researchers who wish  to be able to contribute their expertise and resources toward a better understanding of the impacts of SARS-CoV-2 infection and COVID-19 disease on cancer patients’ disease progression, response to therapy, care delivery, or survivorship may request variance to use a portion of their NCI project funds to address this crisis.
Applications accepted on a rolling basis from May 15, 2020 through January 25, 2022National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel CoronavirusNCATS is interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and then advance the translation of research findings into diagnostics, therapeutics, and vaccines.
Applications accepted on rolling basis from May 15, 2020 to January 25, 2022National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusNCATS is interested in three specific topics: 1) Incorporation of new and emerging data related to SARS-CoV-2 into ongoing research efforts to develop microphysiological systems/tissue chips models for COVID-19; 2) Use of microphysiological systems/tissue chips or evaluating, repurposing or modification of diagnostic tools to enable rapid detection of COVID-19 infection; and 3) Use of microphysiological systems/tissue chips for the rapid development and assessment of potential therapeutic agents for COVID-19
Deadlines begin on or after October 30, 2020 and go through March 16, 2021 - depending on the chosen funding mechanismNational Center for Advancing Translational Sciences (NCATS)Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (NOT-TR-21-006)NCATS is especially interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed Phase I clinical trials to address the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes (COVID-19).
Applications accepted on rolling basis and will be handled on an expedited review and award basis; RFA expires January 24, 2021National Center for Advancing Translational Sciences (NCATS)Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) (RFA-TR-20-003)NCATS will fund early-stage clinical trials on existing therapeutic agents that are already marketed or tested in humans in another Phase I clinical trial prior to application submission.
Applications are due beginning with the October 5, 2020 deadline; this NOSI will expire July 6, 2024National Heart, Lung and Blood Institute (NHLBI)Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) (NOT-HL-20-814)NHLBI will accept applications for R01 projects designed to gain a better understanding of host resilience as a critical determinant of outcomes in acute respiratory distress syndrome/acute lung injury.

June 11, 2021

National Institute of Allergy and Infectious Diseases (NIAID)Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program (NOT-AI-21-002)NIAID will fund highly collaborative, multidisciplinary program project grants (P01) for research to design and develop vaccines capable of broad protection against coronaviruses.
June 4, 2021; optional letters of intent are due 30 days prior

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Environmental Health Sciences (NIEHS)

Immune Development in Early Life

U01 (RFA-AI-20-077)

U19 (RFA-AI-20-078)

Supported research for both Requests for Applications will define the mechanisms regulating the establishment, development and maintenance of immunity through childhood (from birth to <18 years of age). SARS-CoV-2 is specifically mentioned by the sponsors.
Applications accepted on a rolling basis through July 7, 2021National Institute of Allergy and Infectious Diseases (NIAID)Limited Competition Emergency Awards: Shared Personal Protective Resources for COVID-19 Related Vaccine and Treatment Clinical Trials (S10 Clinical Trial Not Allowed) (PAR-20-256)NIAID will provide Personal Protective Equipment (PPE) to directly support the needs of NIAID-funded treatment clinical trials and clinical studies on COVID-19. Eligibility is limited to recipients supported by NIAID's emergency appropriation as outlined in the announcement.
Applications will be accepted on the 14th of every month, starting with September 14, 2020 and ending with September 14, 2021National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates against SARS-CoV-2 (NOT-AI-20-065)NIAID will fund cooperative agreements to implement high-risk clinical trials to augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2; specifically, the sponsor is interested in efforts to evaluate candidate vaccines, non-vaccine medical prevention and therapeutic approaches related to SARS-CoV-2.
Applications accepted on a rolling basis through July 2, 2021.National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AI-20-059)NIAID replaced NOT-AI-20-034, a more open-ended NOSI, with one in which they are specifying limited interest areas as follows: 1) Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response; 2) Creation of critical reagents to support the SARS-CoV-2/COVID-19 research response; 3) Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; and 4) Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities.
Deadlines vary by funding mechanism; this Notice expires September 8, 2021.National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)Research areas are: Studies to understand critical aspects of viral infection, replication, pathogenesis and transmission; Studies on the evolution and emergence of SARS-CoV-2 viruses; Development of diagnostic tests; Development of SARS-CoV-2 therapeutic candidates; Identification and evaluation of the innate, cellular and humoral immune responses to SARS-CoV-2 infection; and Development of SARS-CoV-2 vaccine candidates. NIAID will be using the Small Grant (R03), SBIR and STTR funding mechanisms.
Applications due starting with the February 5, 2021 standard NIH deadline and dependent on funding mechanism selected; NOSI expires November 19, 2021National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Notice of Special Interest (NOSI): Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases (NOT-AR-21-012)NIAMS will support basic, translational, pre-clinical and clinical observational research focused on COVID-19 and its intersection with rheumatic, musculoskeletal and skin diseases/conditions. Specific interests include impact of vaccination on patients with underlying diseases within the NIAMS mission, long-term disease consequences and health disparities.
Proposals may be submitted anytime until further notice; proposal review is promised within one weekNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Fast-Track Program for COVID-19 Test Development and Distribution - Rapid Acceleration of Diagnostics (RADx)The goal of this program is to enable rapid production of innovative SARS-CoV-2 diagnostic tests. Both early and advanced stage projects will be supported.
Deadlines depend on funding mechanism; this NOSI expires March 31, 2021National Institute of Biomedical Imaging and Bioengineering (NIBIB)Notice of Special Interest: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)The sponsor will fund applications to develop life-saving technologies for commercialization within one to two years.
Standard NIH deadlines for R01 and R21 grant mechanisms through July 16, 2023National Institute of Child Health and Human Development (NICHD)Notice of Special Interest (NOSI): Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract (NOT-HD-20-021)NICHD is looking for cutting edge research to investigate possible effects of emerging viruses including SARS-CoV-2 on reproductive tissues and cells to better understand potential impacts in fertility that may be sex specific. Investigators may submit for Research Project (R01) or Exploratory/Developmental Research (R21) Grants.
Deadlines begin on February 5, 2021, depending on the chosen grant mechanism; this NOSI expires March 8, 2023.National Institute of Child Health and Human Development (NICHD)Notice of Special Interest: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic (NOT-HD-20-031)NICHD wishes to fund research addressing the rehabilitation needs of COVID-19 survivors; better understand the impact of disruptions to rehabilitation services caused by COVID-19; and understand the social, behavioral, economic and health impacts of the COVID-19 pandemic on people with physical disabilities. Applications do not have to address all three research interests.
Applications for both types are due February 1, 2021; March 1, 2021; April 1, 2021; and May 3, 2021. This NOSI will expire on May 4, 2021.National Institute of Environmental Health Sciences (NIEHS)Notice of Special Interest: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)NIEHS will support both time-sensitive new projects and emergency competitive revisions from current grantees to study the role of environmental exposures in pathogenicity, transmission, individual susceptability, or prevention and intervention strategies.
The sponsor is using a 2-step application process: Cover page, etc. will be submitted via Grants.gov by February 16, 2021; full applications are then due March 2, 2021 via JustGrantsNational Institute of Justice (NIJ)Research and Evaluation of Services for Victims of Crime (O-NIJ-2021-40005)NIJ indicates they are interested in funding projects researching the impact of COVID-19 on delivery of services to victims of crime.
The sponsor is using a 2-step application process: Cover page, etc. will be submitted via Grants.gov by February 25, 2021; full applications are then due March 11, 2021 via JustGrantsNational Institute of Justice - Office of Juvenile Justice and Delinquency Prevention (OJJDP)Research on Juvenile Justice Topics, Fiscal Year 2021 (NIJ-2021-19113)The overall goal of this program is to support research, evaluations and statistical analyses related to juvenile justice. One priority area is Juvenile Justice Responses to the COVID-19 Pandemic. Specifically, OJJDP will fund research to advance understanding of the effects of juvenile justice responses to the COVID-19 public health crisis on public safety and youth outcomes.
Applications will be accepted on a rolling basis through June 1, 2023National Institute of Mental Health (NIMH)Notice of Special Interest (NOSI): Administrative Supplements for COVID-19 Impacted NIMH Research (NOT-MH-21-120)NIMH will provide administrative supplements to cover unanticipated costs caused by the COVID-19 pandemic. Note that the sponsor will not support COVID-related research through this NOSI.

March 2, 2021

National Institute of Mental Health (NIMH)

Other Participating Institutes and Centers:

National Eye Institute

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute on Drug Abuse

National Institute of Nursing Research

National Institute on Minority Health and Health Disparities

National Center for Complementary and Integrative Health

 

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) (PAR-20-243)NIMH and partner Institutes and Centers will support research to determine the role and impact of digital-health interventions (e.g., mobile health, telemedicine and telehealth, health information technology, wearable devices) to address secondary health effects of the social, behavioral and economic changes following the COVID-19 pandemic, particularly among populations who experience health disparities and vulnerable populations.
Applications will be accepted on a rolling basis through April 15, 2021.

National Institute of Mental Health (NIMH)

 

Other Participating Institutes:

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel CoronavirusNIMH is especially interested in research to (1) provide an evidence base for how a disrupted workforce may respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, (2) learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health and (3) address the intersection of COVID-19, mental health, and HIV treatment and prevention.
Not applicableNational Institute of Mental Health (NIMH)Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency Caused by Coronavirus 2019 (COVID-19) (NOT-MH-20-061)With the overall goal of more effective human subjects data harmonization, NIMH is offering guidance on the use of consensus-derived common data elements (CDEs) pertaining to mental health outcomes including a set of newly available measures regarding experiences during the COVID-19 public health emergency and exposures to the SARS-CoV-2 virus.
Applications accepted through April 14, 2021

National Institute of Neurological Disorders and Stroke (NINDS)

Other Participating Institutes:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous SystemNINDS will support supplements to address the biology, pathophysiology, prevention, diagnosis, sequelae or treatment of the Novel Coronavirus 2019; NIAAA is interested in studies to better understand, prevent and mitigate some of the neurobiological consequences of SARS-CoV-2 and COVID-19 in individuals with Alcohol Use Disorders.
February 1, 2021National institute on Aging (NIA)NIA Multi-Site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Adult Populations (R01 Clinical Trial Required) (PAR-20-234)NIA will support investigator-initiated multi-site clinical trials of interventions focused on specific aging-related issues to reduce transmission, risk, morbidity, mortality or complications of COVID-19; see program announcement for specific priorities.

Applications accepted on a rolling basis from April 6, 2020 through May 1, 2021 with exception of NIA which has indicated they are withdrawing effective December 1, 2020

 

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Other Participating Institutes:

National Institute of Mental Health (NIMH)

National Institute on Aging (NIA)

Notice of Special Interest: NIH Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (NOT-AG-022)

See Notice of NIA withdrawal from this NOSI effective December 1, 2020

 

FAQ Document

This NOSI is designed to address the urgent public health need to better understand the 2019-nCoV, particularly to improve prevention of disease transmission among older adults and mitigation of disease severity/mortality in older adults with COVID-19.
Applications accepted on rolling basis through April 15, 2021National Institute on Alcohol Abuse and Alcoholism (NIAAA)Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAANIAAA is requesting applications to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes.
October 5, 2020 through September 8, 2022 (dependent on specific program announcement - R01 or R21)National Institute on Deafness and Other Communication Disorders (NIDCD)Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders (NOT-DC-20-008)NIDCD will support research on COVID-19 in relation to the Institute's scientific programs: hearing, balance, taste, smell, voice, speech and language.
March 31, 2021National Institute on Drug Abuse (NIDA)

HEAL Initiative:

HEALthy Brain and Child Development Study (Collaborative U01) (RFA-DA-21-020)

HEALthy Brain and Child Development Study (U01) (RFA-DA-21-021)

HEALthy Brain and Child Development Consortium Administrative Core (U24) (RFA-DA-21-022)

HEALthy Brain and Child Development Data Coordinating Center (U24) (RFA-DA-21-023)

This related set of Requests for Applications will entertain COVID-19 related research questions in terms of adverse environmental exposures and later neurodevelopmental outcomes.
Will accept applications for deadlines on or after January 7, 2021 through September 8, 2024National Institute on Drug Abuse (NIDA)Notice of Special Interest (NOSI): Effects of Smoking and Vaping on the Risk and Outcome of COVID-19 Infection (NOT-DA-20-084)NIDA would like to gain a better understanding of the risks of acquiring COVID-19 and medical consequences of COVID-19 as it relates to those who smoke or vape tobacco or marijuana. Medical consequences may extend to those who smoke or vape with co-morbid conditions.
February 8, 2021
June 8, 2021
October 8, 2021
National Institute on Drug Abuse (NIDA)Notice of Clarification to PAR-19-064, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) (NOT-DA-20-062)NIDA has released a Notice of Clarification for this program announcement, adding an additional priority area concerning risks and outcomes associated with substance use and COVID-19 infection in the general population and among underserved populations.
March 17, 2021
November 17, 2021
March 17, 2022
November 17, 2022
February 17, 2023

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating NIH Components:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse (NIDA)

Health Services Research on Minority Health and Health Disparities (R01 - Clinical Trial Optional) (PAR-20-310)The sponsor is encouraging health services research efforts that will directly contribute to the improvement of minority health and/or the reduction of health disparities. Research interests include COVID-19.

Standard NIH deadlines apply; the first deadline will be October 5, 2020; the program announcement expires September 8, 2023

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute on Drug Abuse (NIDA)

National Cancer Institute (NCI)

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 - Clinical Trial Optional) (PA-20-172)Will support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters (to include COVID-19) on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.
Applications accepted on rolling basis through May 1, 2021

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute of Mental Health (NIMH)

Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health DisparitiesNIMHD is soliciting research in health disparity populations to better understand: 1) how state and local policies and initiatives mitigate/exacerbate disparities in health services use and health outcomes; 2) the role that community-level protective and resilience factors and interventions have in mitigating the effects of the sector disruptions that the COVID-19 outbreak causes; and 3) how behavioral and/or biological mechanisms may contribute to COVID-19 manifestations.
Applications are due according to the NIH standard deadline schedule for R01s, beginning with the February 5, 2021 deadline; this NOSI expires January 8, 2022.

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating NIH Components:

National Heart, Lung and Blood Institute (NHLBI)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

National Cancer Institute (NCI)

Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake and Implementation among Populations that Experience Health Disparities (NOT-MD-21-008)NIMHD and partnering Institutes will fund community-engaged research to 1) evaluate intervention strategies to facilitate vaccination (including SARS-CoV-2) uptake in clinical and community contexts, and 2) address the barriers to increasing reach, access and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy. 
N/ANational Institutes of Health (NIH)Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency (NOT-OD-20-118)NIH has issued a reminder relative to a number of COVID-19 Notices of Special Interest that the agency has "resources and guidance that will facilitate data harmonization and the development of robust data sharing plans."
This opportunity opens for applications starting February 5, 2021 and expires January 8, 2024.National Institutes of Health (NIH)Notice of Special Interest (NOSI): Academy of Finland (AKA) - National Institutes of Health (NIH) Partnership Program (NOT-OD-21-021)Designed to foster expansion of US-Finland biomedical and behavioral research collaborations, this joint research program has at least one COVID-19 related opportunity: To utilize lessons learned from cancer research for COVID-19 treatments.
March 5, 2021National Institutes of HealthNotice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-21-020)Note that only the National Heart, Lung and Blood Institute (NHLBI) references the COVID-19 pandemic as an interest. NIH will fund administrative supplements for research related to bioethical issues as well as capacity building efforts surrounding bioethics.

March 12, 2021

July 12, 2021

National Institutes of Health (multiple Institutes and Centers)Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down syndrome for the INCLUDE Project (NOT-OD-20-129)The goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population which may be disproportionately affected by, and/or be at elevated risk for, adverse outcomes from contracting the virus. Multiple institutes and centers are participating and each have specified research objectives as listed in the Notice.
Applications will be accepted according to the standard R01 deadline schedule, starting October 5, 2020; this NOSI expires May 8, 2021

National Institutes of Health (NIH)

Participating NIH Components:

National Institute of Minority Health and Health Disparities

National Institute of Mental Health

National Institute on Drug Abuse

Office of Disease Prevention

National Institute on Deafness and Other Communication Disorders

National Cancer Institute

National Library of Medicine

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities (NOT-MD-20-025)The purpose of this NOSI is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities across a range of illnesses and conditions including the novel coronavirus pandemic.

No set deadline for proposals in response to Dear Colleague Letter

National Science Foundation (NSF)Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)

NSF encourages investigators to use the Rapid Response Research (RAPID) funding mechanism to address COVID-19 which allows for quick turnaround time to meet project requirements. The first step is to contact the program officer as RAPID proposals require program officer permission to submit.

NSF is also encouraging investigators to submit to existing funding opportunities such as the Ecology and Evolution of Infectious Diseases program (EEID), jointly funded by NSF, NIH, USDA and others; EEID proposals are due November 18, 2020.

Proposals for Medium projects may be submitted anytime

National Science Foundation/National Institutes of Health (and a host of other federal agencies)Cyber-Physical Systems (CPS)Core research areas of this initiative are control, data analytics and machine learning. NIH mentions supporting "development of CPS research and technology to facilitate medical treatment during a national crisis (e.g., SARS-CoV-2)" (see Section II.D.3 of the program solicitation for details).
March 31, 2021National Science Foundation (NSF)Dear Colleague Letter: Future of International Research Collaboration Post COVID-19NSF's Office of International Science and Engineering (OISE) is interested in funding Rapid Response Research (RAPID) and EArly-concept Grants for Exploratory Research (EAGER) proposals addressing lessons learned from the COVID-19 pandemic that will ultimately benefit international collaborative research efforts.
No set deadlineNational Science Foundation (NSF)Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-2019)

NSF is inviting RAPID proposals and supplemental funding requests to existing awards to address COVID-19 challenges through data and/or software infrastructure development activities. Again, program officer permission is required prior to proposal submission.

January 29, 2021National Science Foundation (NSF)Dear Colleague Letter: Requesting Proposals for Online Biology Education to the Research Coordination Network for Undergraduate Biology Education (NSF 21-026)COVID-19 has resulted in most undergraduate students participating in online or hybrid courses. The Directorates for Biological Sciences and Education and Human Resources are interested in projects focused on developing, piloting and sharing innovative approaches for online undergraduate biology courses. NSF is particularly interested in supporting projects that foster inclusive approaches that encourage student engagement and retention in biology.
Proposals accepted anytimeNational Science Foundation (NSF)Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) (NSF 20-105)Noting that COVID-19 is unlikely to be the last pandemic in our lifetime, NSF is encouraging use of synthetic biology, cellular engineering, biosensing and immunoengineering as well as other approaches at the intersection of biology and engineering to address the threat of emerging infectious diseases.
March 23, 2021National Science Foundation (NSF)Future of Work at the Human-Technology Frontier: Core Research (NSF 21-548)Within the context of research addressing advanced understanding of future work and work outcomes for workers and society, NSF will consider proposals focused on the impact of large-scale disruptions such as the COVID-19 pandemic on the future of jobs and work.
Applications accepted on a rolling basis through March 31, 2021

Office of Behavioral and Social Sciences Research (OBSSR) (within National Institutes of Health)

 

Other Participating Institutes:

National Heart, Lung and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute

Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social SciencesOBSSR is encouraging urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.

November 26, 2021

Office of Research on Women's Health (ORWH) (within National Institutes of Health)Notice of Change: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) (RFA-OD-20-168)ORWH has issued a Notice of Change for their ongoing Request for Applications (RFA) to include the influence of sex- and gender-related risk factors associated with COVID-19 disease prevalence, treatment and prevention. Studies examining health-seeking behaviors, access to health care and health care systems as related to COVID-19 are also within scope.
February 1, 2021Olympic Studies CentreAdvanced Olympic Research Grant ProgramOne of the research priorities this year is the place of sport and physical activity in the health sector as both prevention and primary healthcare tools against non-communicable diseases – Analysis of the trends of the political discourse and policies of national governments as a response to the COVID19 pandemic with a particular interest in future Olympic Games host countries.
Required letters of intent are due February 1, 2021; invited full applications will then be due May 4, 2021.Patient-Centered Outcomes Research Institute (PCORI)Broad PCORI Funding Announcements: Addressing Disparities; Assessment of Prevention, Diagnosis and Treatment Options; Communication and Dissemination Research; and Improving Healthcare Systems (Cycle 1 2021)PCORI has designated COVID-19 as a Special Emphasis Area for their Cycle 1 2021 Broad PCORI Funding Announcement (PFA). Priority topics are management and survivorship of post-acute COVID-19; impact of COVID-19 on disproportionately affected populations; and impact of COVID-19-related social isolation and loneliness on health outcomes.
None listedPfizerCOVID-19 Vaccine GrantsThrough their Global Medical Grants Program, Pfizer is implementing their COVID-19 Vaccine Grants in phases. Current interest areas are: 1) Studies evaluating COVID-19 burden of disease and sero-epidemiological surveys among specific populations; 2) Epidemiological studies evaluating direct and indirect impact, including modeling approaches, of Pfizer's vaccine particularly in specific populations; and 3) Studies measuring the impact of efforts to overcome vaccine hesitancy and enhance vaccine uptake.
February 10, 2021PfizerCOVID-19 Vaccine Patient Education: Addressing Vaccine HesitancyPfizer will support patient education programs designed to increase understanding and familiarity with COVID-19 and COVID-19 vaccination.
May 4, 2021 - deadline for required Letters of InquiryRussell Sage FoundationResearch GrantsThe Foundation's core programs are Future of Work; Immigration and Immigrant Integration; Race, Ethnicity and Immigration; Social, Political and Economic Inequality. Within these core programs, applicants may address this topic: Research on the COVID-19 pandemic and the resulting recession in the US.
Required letters of intent are due January 28, 2021 and July 28, 2021; invited full proposals will then be due March 24, 2021 or September 22, 2021.Tinker FoundationInstitutional Grants: Education ProgramThe Foundation's overall goal is to support changes to policy and practice that improve the lives of Latin Americans. They have implemented a special initiative related to their Education Program - Ensuring Educational Equity During the Covid-19 Pandemic.

Participants must register by December 8, 2020. 

Phase One - Predictor Development closes December 22, 2020.

Phase Two - Prescriptor Development will close February 3, 2021.

XPrize FoundationXPRIZE Pandemic Response ChallengeParticipants will develop models that predict local COVID-19 outbreaks with more accuracy along with prescriptive intervention and mitigation approaches that minimize infection cases and economic costs. There will be two phases: Predictor Development and Prescriptor Development.